Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 1:6:19.
doi: 10.3389/fonc.2016.00019. eCollection 2016.

Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination

Affiliations
Review

Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination

Anna Louise Beavis et al. Front Oncol. .

Abstract

Human papillomavirus (HPV) vaccination rates for preadolescent and adolescent girls in the United States are far behind those of other developed nations. These rates differ substantially by region and state, socioeconomic status, and insurance status. In parents and young women, a lack of awareness and a misperception of the risk of this vaccine drive low vaccination rates. In physicians, lack of comfort with discussion of sexuality and the perception that the vaccine should be delayed to a later age contribute to low vaccination rates. Patient- and physician-targeted educational campaigns, systems-based interventions, and school-based vaccine clinics offer a variety of ways to address the barriers to HPV vaccination. A diverse and culturally appropriate approach to promoting vaccine uptake has the potential to significantly improve vaccination rates in order to reach the Healthy People 2020 goal of over 80% vaccination in adolescent girls. This article reviews the disparities in HPV vaccination rates in girls in the United States, the influences of patients', physicians', and parents' attitudes on vaccine uptake, and the proposed interventions that may help the United States reach its goal for vaccine coverage.

Keywords: HPV; cervical cancer; disparities; health policy; vaccination.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Uptake and completion rates of HPV vaccination by state. This graph shows the percentage of female adolescents aged 13–17 who initiated and completed the HPV vaccination series in the United States in 2014, by state. HPV vaccination uptake ranges from 76% in Rhode Island to 38.3% in Kansas (15). The 10 states with the highest cervical cancer incidence rates according to the CDC in 2012 are marked with *; most are among those with the lowest HPV vaccination rates (24). HPV vaccination rates adapted from the NIS-Teen survey data reported in Reagan-Steiner et al., (15). DC, District of Columbia; HPV, human papillomavirus.

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin (2015) 65(1):5–29.10.3322/caac.21254 - DOI - PubMed
    1. Simard EP, Naishadham D, Saslow D, Jemal A. Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol (2012) 127(3):611–5.10.1016/j.ygyno.2012.08.021 - DOI - PubMed
    1. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine (2008) 26(Suppl 1):K53–61.10.1016/j.vaccine.2008.06.002 - DOI - PMC - PubMed
    1. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 63(RR–05):1–30. - PubMed
    1. Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med (2015) 372(8):711–23.10.1056/NEJMoa1405044 - DOI - PubMed

LinkOut - more resources